Journal of Liver

World Congress on Hepatitis

July 20-22, 2015 Orlando, Florida, USA

Posters-Accepted Abstracts

• Transient elastography-based model for assessment of portal hypertension in patient with HCV and Alcohol-related liver cirrhosis

  Liusina E O, Pavlov C S and Ivashkin V T

  PDF HTML

• Discovery of potential biomarkers from Chronic Hepatitis B to cirrhosis by cytokine profiling analysis

  Shi-Bing Su, Yi-Yu Lu, Yu Zhao, Shu Dong, Bin Wei, Qi-Long Chen, Hui Zhang and Yi-Yang Hu

  PDF HTML

• Establishment of Anti-hepatocellular Carcinoma drug screening platform in zebrafish

  Chiou-Hwa Yuh

  PDF HTML

• Salivary pH as an indicator for Hepatocellular carcinoma

  Maha Hussein, Heba Elnazer, Sayed Shalaby and Mohamed Makhlouf

  PDF HTML

• Study of factors contributing to Persistent thrombocytopenia following Liver transplantation

  Tari George, Maha Hussein, Mohsen Maher, Mahmoud Elmeteini, Mohamed Bahaa and Manal Mohsen

  PDF HTML

• Shaped magnetic composites as dual modal targeted molecular CT/MRI imaging tools of Hepatocarcinoma

  Anamaria Orza

  PDF HTML

• The role of stem cell factor in the regeneration after toxic Liver injury

  Danilova I1, 2, Medvedeva S1, 2, Bulavintseva T1, 2 and Mukhlynina E1,2

  PDF HTML

• Aflatoxin levels in Chronic Hepatitis B patients with cirrhosis or Hepatocellular carcinoma in Balikesir, Turkey

  Sevtap Aydin

  PDF HTML

• Morphological features in Liver of young people with chronic Hepatitis C

  Blinkova N1, Vedenskaya S2 and Gruzdev M2

  PDF HTML

• Small for size syndrome after extended Hepatectomy: New scenarios opened by flow theory. A case series and related therapy recommendations

  Simone Famularo

  PDF HTML

• TLR expression and liver microflora in HCV-related cirrhosis and Hepatocellular carcinoma

  Anil Kaul

  PDF HTML

• Ligase chain reaction as a modality for the detection of point mutation in the precore region of HBV related HCC cases from Northern India

  Abdul Malik

  PDF HTML

• IL30: A biological cytokine provides hepatic protection in Chronic inflammation mediated liver fibrosis

  Abhisek Mitra

  PDF HTML

• Overexpression of GLUT2/ Slc2a2 are accompanied by Hnf-1?, Hnf-4? and Hnf-3? transcriptional regulation in liver of Nonalcoholic steatohepatitis obese diabetic mice

  Aline D Silva, Rodolfo R Favaro, Daniela T Furuya, Patrícia E Silva, Luciana Tocci Belpiede, Helayne S Freitas, Maristela M Okamoto, Fernanda Barrence, Telma M T Zorn and Ubiratan F Machado

  PDF HTML

• The Doylestown algorithm- A test to improve the performance of AFP in the detection of Hepatocellular carcinoma

  Anand Mehta1, Mengjun Wang1, Karthik Devarajan2 and Timothy M Block3

  PDF HTML

• Successful extracorporeal resuscitation after perioperative anaphylactic shock during living donor liver transplantation

  Ching-Hui Shen

  PDF HTML

• Efficacy of HBVneonatal vaccination, catch-up vaccination and adolescence booster on Chronic HBV infection in rural area of China

  Chunfeng Qu

  PDF HTML

• First evidence of Hepatitis B virus (HBV) infection in free ranging Neotropical primates, Rondonia, Brazil

  Deusilene Souza Vieira Dall’Acqua

  PDF HTML

• The natural history of chronic Hepatitis B and C infection in the United States

  Joanne C Imperial

  PDF HTML

• Advances in hepatic stem/progenitor cell biology and their therapeutic potential for liver diseasescurrent scenario

  Dollé Laurent, Stefaan Verhulst, Jan Best, Kimberly Lagaisse, Danielle Blyweert and Leo A Van Grunsven

  PDF HTML

• Use of contingency management incentives to improve completion of Hepatitis B vaccination in people undergoing treatment for heroin dependence: A cluster randomized trial

  John Strang

  PDF HTML

• Innovating liver advocacy

  Donna R Cryer

  PDF HTML

• Dual face functional role of IL-33 during immune cell mediated and hepato-toxic induced acute liver injury

  Michel Samson

  PDF HTML

• HBsAg Quantification: Useful for monitoring natural history and treatment outcome

  Michelle Martinot-Peignoux

  PDF HTML

• Humoral and cellular immune responses in mice against modified Hepatitis B plasmid DNA vaccine

  Mounir M Salem-Bekhit1, 2, Mahmoud M Tawfick1 and Mohsn A Bayoumi2

  PDF HTML

• Proteomics studies of the impact of high fat diet on proteome of mouse liver and dual mode of pharmacological action of Mangiferin

  Yuling Chi

  PDF HTML

• Hepatic DNA deposition drives drug-induced liver injury and inflammation

  Pedro Elias Marques

  PDF HTML

• Risk assessment of the fungal metabolite, Fumonisin B1 in humans: A hepatotoxic and –carcinogenic contaminant in corn

  WCA Gelderblom

  PDF HTML

• The management of Hepatitis B infection in kidney transplant recipients

  YapYat-Hin Desmond

  PDF HTML

• New advances in approaching of the alteration of Intrahepatic microcirculation in cirrhotic livers

  Ying-Ying Yang

  PDF HTML